EB

Eric Bradford

Chief Development Officer at Aeglea BioTherapeutics

Eric Bradford, MD, MSc, MBA, is the Chief Medical Officer at Areteia Therapeutics. Prior to this role, Eric held positions at Aeglea BioTherapeutics and GSK, where Eric gained extensive experience in clinical development and global product strategy. Eric's academic background includes degrees from Stanford University, University of Virginia, and University of North Carolina at Chapel Hill School of Medicine.

Links

Timeline

  • Chief Development Officer

    August, 2020 - present

  • Vice President, Clinical Development

    April, 2020